Therapeutic perspectives of <em>p</em>‑coumaric acid: Anti‑necrotic, anti‑cholestatic and anti‑amoebic activities

Aldaba‑Muruato,Liseth Rubí; Ventura‑Juárez,Javier; Perez‑Hernandez,Alan Michael; Hernández‑Morales,Alejandro; Muñoz‑Ortega,Martin Humberto; Martínez‑Hernández,Sandra Luz; Alvarado‑Sánchez,Brenda; Macías‑Pérez,José Roberto

doi:10.3892/wasj.2021.118

Therapeutic perspectives of p‑coumaric acid: Anti‑necrotic, anti‑cholestatic and anti‑amoebic activities

Authors:
- Liseth Rubí Aldaba‑Muruato
- Javier Ventura‑Juárez
- Alan Michael Perez‑Hernandez
- Alejandro Hernández‑Morales
- Martin Humberto Muñoz‑Ortega
- Sandra Luz Martínez‑Hernández
- Brenda Alvarado‑Sánchez
- José Roberto Macías‑Pérez
View Affiliations

Affiliations: Department of Clinical Chemistry, Faculty of Professional Studies Huasteca Zone, Autonomous University of San Luis Potosí, Ciudad Valles, San Luis Potosí 79060, Mexico, Department of Morphology, Basic Sciences Center, Autonomous University of Aguascalientes, Aguascalientes 20131, Mexico, Department of Biochemistry, Faculty of Professional Studies Huasteca Zone, Autonomous University of San Luis Potosí, Ciudad Valles, San Luis Potosí 79060, Mexico, Department of Chemistry, Basic Sciences Center, Autonomous University of Aguascalientes, Aguascalientes 20131, Mexico
Published online on: July 26, 2021 https://doi.org/10.3892/wasj.2021.118
Article Number: 47
Copyright: © Aldaba‑Muruato et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Phenolic acids are phytochemical compounds derived from plant biomass materials, that have notable health benefits with high therapeutic potential in several diseases. p‑coumaric acid (p‑CA) is a phenolic acid that displays various biological activities, such as antioxidant, anti‑inflammatory, analgesic and anti‑antimicrobial properties. However, the ability of p‑CA to prevent hepatic necrosis and cholestasis induced by various harmful agents has not yet been explored to date, at least to the best of our knowledge, and there is no evidence that p‑CA exerts an anti‑parasitic effect. Therefore, the present study employed male Wistar rats, and the study was divided into two experimental in vivo parts. A liver necrosis model was established using carbon tetrachloride (CCl4) for 24 h, and a cholestasis model induced by common bile duct ligation (BDL) for 48 h was also established. On the other hand, the Entamoeba histolytica HM1:IMSS strain was used as in vitro model employing Trypan blue cell viability assay. The results revealed that p‑CA treatment significantly reduced the levels of the necrosis biomarker, alanine aminotransferase, and completely prevented the increase in the levels of the cholestasis markers, alkaline phosphatase and γ‑glutamyl transpeptidase in rats intoxicated with CCl₄ as well as in those subjected to BDL. Macroscopic observations and the hematoxylin and eosin staining results were consistent with the biochemical determinations, providing evidence of the hepatoprotective effects of p‑CA. Moreover, 500 µM p‑CA inhibited the growth of Entamoeba histolytica, 26.5% at 12 h and 41.5% at 24 h compared with the controls. Thus, to the best of our knowledge, these findings provide the first evidence that p‑CA prevents liver damage induced by CCl₄ or BDL (necrosis and cholestasis) and exhibits amoebostatic activity against Entamoeba histolytica.

View Figures

View References

1	Białecka-Florjańczyk E, Fabiszewska A and Zieniuk B: Phenolic acids derivatives - biotechnological methods of synthesis and bioactivity. Curr Pharm Biotechnol. 19:1098–1113. 2018.PubMed/NCBI View Article : Google Scholar
2	Kumar N and Goel N: Phenolic acids: Natural versatile molecules with promising therapeutic applications. Biotechnol Rep (Amst). 24(pe00370)2019.PubMed/NCBI View Article : Google Scholar
3	Nwidu LL, Nwafor PA, da Silva VC, Rodrigues CM, dos Santos LC, Vilegas W and Nunes-de-Souza RL: Anti-nociceptive effects of Carpolobia lutea G. Don (Polygalaceae) leaf fractions in animal models. Inflammopharmacology. 19:215–225. 2011.PubMed/NCBI View Article : Google Scholar
4	Nwidu LL, Essien GE, Nwafor PA and Vilegas W: Antidiarrheal mechanism of Carpolobia lutea leaf fractions in rats. Pharm Biol. 49:1249–1256. 2011.PubMed/NCBI View Article : Google Scholar
5	El-Seedi HR, El-Said AM, Khalifa SA, Göransson U, Bohlin L, Borg-Karlson AK and Verpoorte R: Biosynthesis, natural sources, dietary intake, pharmacokinetic properties, and biological activities of hydroxycinnamic acids. J Agric Food Chem. 60:10877–10895. 2012.PubMed/NCBI View Article : Google Scholar
6	Pei K, Ou J, Huang J and Ou S: p-Coumaric acid and its conjugates: Dietary sources, pharmacokinetic properties and biological activities. J Sci Food Agric. 96:2952–2962. 2016.PubMed/NCBI View Article : Google Scholar
7	Hong SY, Jeong WS and Jun M: Protective effects of the key compounds isolated from Corni fructus against β-amyloid-induced neurotoxicity in PC12 cells. Molecules. 17:10831–10845. 2012.PubMed/NCBI View Article : Google Scholar
8	Piñeiro-Carrero VM and Piñeiro EO: Liver. Pediatrics. 113 (Suppl 4):1097–1106. 2004.PubMed/NCBI
9	Upcroft P and Upcroft JA: Drug targets and mechanisms of resistance in the anaerobic protozoa. Clin Microbiol Rev. 14:150–164. 2001.PubMed/NCBI View Article : Google Scholar
10	Parvizi F, Yaghmaei P, Haeri Rohani SA and Mard SA: Hepatoprotective properties of p-coumaric acid in a rat model of ischemia-reperfusion. Avicenna J Phytomed. 10:633–640. 2020.PubMed/NCBI
11	Ekinci Akdemir FN, Albayrak M, Çalik M, Bayir Y and Gülçin İ: The protective effects of p-coumaric acid on acute liver and kidney damages induced by cisplatin. Biomedicines. 5(E18)2017.PubMed/NCBI View Article : Google Scholar
12	Frank D, Savir S, Gruenbaum BF, Melamed I, Grinshpun J, Kuts R, Knyazer B, Zlotnik A, Vinokur M and Boyko M: Inducing acute liver injury in rats via carbon tetrachloride (CCl₄) exposure through an orogastric tube. J Vis Exp: Apr 28, 2020 (Epub ahead of print). doi: 10.3791/60695.
13	Van Campenhout S, Van Vlierberghe H and Devisscher L: Common bile duct ligation as model for secondary biliary cirrhosis. Methods Mol Biol. 1981:237–247. 2019.PubMed/NCBI View Article : Google Scholar
14	Georgiev P, Jochum W, Heinrich S, Jang JH, Nocito A, Dahm F and Clavien PA: Characterization of time-related changes after experimental bile duct ligation. Br J Surg. 95:646–656. 2008.PubMed/NCBI View Article : Google Scholar
15	Reitman S and Frankel S: A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J Clin Pathol. 28:56–63. 1957.PubMed/NCBI View Article : Google Scholar
16	Glossmann H and Neville DM: gamma-glutamyltransferase in kidney brush border membranes. FEBS Lett. 19:340–344. 1972.PubMed/NCBI View Article : Google Scholar
17	Bergmeyer HU, Grabl M and Walter HE: Enzymes. In: Methods of Enzymatic Analysis, a.M.G.V.-C.W. Bergmeyer J (ed), pp269-270, 1983.
18	Luna LG: Manual of Histologic Staining Methods of the Arme Forces Institute of Pathology. 3rd edition. McGraw-Hill, New York, NY, 1968.
19	Diamond LS, Harlow DR and Cunnick CC: A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba. Trans R Soc Trop Med Hyg. 72:431–432. 1978.PubMed/NCBI View Article : Google Scholar
20	Strober W: Trypan blue exclusion test of cell viability. Curr Protoc Immunol: May 1, 2015 (Epub ahead of print). doi: 10.1002/0471142735.ima03bs21.
21	Li S, Tan HY, Wang N, Zhang ZJ, Lao L, Wong CW and Feng Y: The role of oxidative stress and antioxidants in liver diseases. Int J Mol Sci. 16:26087–26124. 2015.PubMed/NCBI View Article : Google Scholar
22	Sun M and Kisseleva T: Reversibility of liver fibrosis. Clin Res Hepatol Gastroenterol. 39 (Suppl 1):S60–S63. 2015.PubMed/NCBI View Article : Google Scholar
23	Luedde T, Kaplowitz N and Schwabe RF: Cell death and cell death responses in liver disease: Mechanisms and clinical relevance. Gastroenterology. 147:765–783.e4. 2014.PubMed/NCBI View Article : Google Scholar
24	Kanduc D, Mittelman A, Serpico R, Sinigaglia E, Sinha AA, Natale C, Santacroce R, Di Corcia MG, Lucchese A, Dini L, et al: Cell death: Apoptosis versus necrosis (Review). Int J Oncol. 21:165–170. 2002.PubMed/NCBI
25	Boll M, Weber LW, Becker E and Stampfl A: Mechanism of carbon tetrachloride-induced hepatotoxicity. Hepatocellular damage by reactive carbon tetrachloride metabolites. Z Naturforsch C J Biosci. 56:649–659. 2001.PubMed/NCBI View Article : Google Scholar
26	Deniz GY, Laloglu E, Koc K, Nadaroglu H and Geyikoglu F: The effect of black mulberry (Morus nigra) extract on carbon tetrachloride-induced liver damage. Arch Biol Sci. 70:371–378. 2018.
27	Sokol RJ, Devereaux M, Dahl R and Gumpricht E: ‘Let there be bile’ - understanding hepatic injury in cholestasis. J Pediatr Gastroenterol Nutr. 43 (Suppl 1):S4–S9. 2006.PubMed/NCBI View Article : Google Scholar
28	Cha H, Lee S, Lee JH and Park JW: Protective effects of p-coumaric acid against acetaminophen-induced hepatotoxicity in mice. Food Chem Toxicol. 121:131–139. 2018.PubMed/NCBI View Article : Google Scholar
29	Li M, Cai SY and Boyer JL: Mechanisms of bile acid mediated inflammation in the liver. Mol Aspects Med. 56:45–53. 2017.PubMed/NCBI View Article : Google Scholar
30	Mariotti V, Cadamuro M, Spirli C, Fiorotto R, Strazzabosco M and Fabris L: Animal models of cholestasis: An update on inflammatory cholangiopathies. Biochim Biophys Acta Mol Basis Dis. 1865:954–964. 2019.PubMed/NCBI View Article : Google Scholar
31	Glaser SS, Onori P, Wise C, Yang F, Marzioni M, Alvaro D, Franchitto A, Mancinelli R, Alpini G, Munshi MK, et al: Recent advances in the regulation of cholangiocyte proliferation and function during extrahepatic cholestasis. Dig Liver Dis. 42:245–252. 2010.PubMed/NCBI View Article : Google Scholar
32	Chou A and Austin RL: Entamoeba Histolytica. StatPearl, Treasure Island, FL, 2021.
33	Zulfiqar H, Mathew G and Horrall S: Amebiasis. StatPearls, Treasure Island, FL, 2021.
34	Kantor M, Abrantes A, Estevez A, Schiller A, Torrent J, Gascon J, Hernandez R and Ochner C: Entamoeba Histolytica: Updates in Clinical Manifestation, Pathogenesis, and Vaccine Development. Can J Gastroenterol Hepatol. 2018(4601420)2018.PubMed/NCBI View Article : Google Scholar
35	Wassmann C, Hellberg A, Tannich E and Bruchhaus I: Metronidazole resistance in the protozoan parasite Entamoeba histolytica is associated with increased expression of iron-containing superoxide dismutase and peroxiredoxin and decreased expression of ferredoxin 1 and flavin reductase. J Biol Chem. 274:26051–26056. 1999.PubMed/NCBI View Article : Google Scholar
36	Degerli S and Tepe B: Phenolic acid composition and anti-parasitic effects of four peucedanum species on Entamoeba histolytica Trophozoites. Iran J Parasitol. 10:420–431. 2015.PubMed/NCBI